Benzo[a]pyrene inhibits osteoclastogenesis by affecting RANKL-induced activation of NF-kappaB

Area of Science:

• Environmental Toxicology
• Cellular Biology
• Molecular Signaling

Background:

• Polycyclic aryl hydrocarbons, like benzo[a]pyrene (BaP), are environmental pollutants linked to adverse health effects.
• BaP exposure is known to inhibit osteoclast differentiation and bone resorption.
• The underlying mechanism may involve crosstalk between signaling pathways.

Purpose of the Study:

• To investigate the hypothesis that BaP inhibits osteoclastogenesis via crosstalk between the aryl hydrocarbon receptor (AhR) and receptor activator of NF-kappaB ligand (RANKL) signaling pathways.
• To determine the role of the transcription factor NF-kappaB in BaP-mediated effects on osteoclast differentiation.

Main Methods:

• RAW264.7 cells were treated with varying concentrations of RANKL and BaP.
• NF-kappaB activation, nuclear translocation, and CYP1B1 gene expression were measured.
• NF-kappaB inhibitors and reporter gene assays were employed.
• Co-immunoprecipitation was used to assess protein interactions.

Main Results:

• BaP inhibited RANKL-induced NF-kappaB activation and nuclear translocation.
• NF-kappaB inhibitors dose-dependently reduced BaP-induced CYP1B1 gene expression.
• Both BaP and RANKL induced NF-kappaB-driven reporter gene transcription.
• BaP enhanced AhR interaction with NF-kappaB p65, but this interaction was not observed in the presence of RANKL.

Conclusions:

• BaP inhibits osteoclast differentiation by competing for the transcription factor NF-kappaB.
• Crosstalk between AhR and RANKL signaling pathways, mediated by NF-kappaB, is a key mechanism in BaP's effect on osteoclastogenesis.